Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 30 points on Wednesday.
The Dow traded up 0.12% to 32,695.97 while the NASDAQ fell 0.23% to 11,429.16. The S&P 500 also fell, dropping, 0.17% to 3,963.32.
Movie theater leader AMC Entertainment Holdings Inc (NYSE: AMC) reported fourth-quarter financial results after market close Tuesday. The company also shared an update on liquidity and a planned shareholder vote.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) will commence adult-use sales at its Hartford, Connecticut location beginning March 1 at 9:00 am EST.
Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) cannabis lifestyle brand CANACA, is launching Bursts and Darts. Joining the CANACA family, the four new SKUs include Fruitsplosion and
Cidara Therapeutics Inc (NASDAQ: CDTX) announced efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388 against the H3N2 influenza A virus strain.
LL Flooring Holdings, Inc. (NYSE:LL) reported a fourth-quarter sales decline of 7.5% year-on-year to $263.87 million, missing the consensus of $267.60…